Regulatory services in clinical research involve ensuring that clinical trials and medicinal products comply with applicable laws, regulations, ethical requirements, and regulatory guidelines throughout the product-development lifecycle.
Our regulatory team works alongside sponsors from early development strategy through post-approval maintenance, following a structured workflow: development strategy, regulatory consultation, document preparation, submission, regulatory review, responses and clarifications, approval, and post-approval maintenance.
This end-to-end support helps sponsors navigate health authority and ethics committee requirements with confidence, keeping programs on track and audit-ready at every stage.
We support sponsors across regulatory strategy, submissions, and post-approval maintenance, ensuring programs stay compliant with evolving regulations and guidelines.
Developing the overall regulatory pathway and preparing submissions to health authorities and ethics committees/IRBs.
Supporting preparation and submission of documents required to initiate trials, including IND applications and CTAs.
Managing regulatory aspects of expedited safety reporting, periodic safety reports, and risk-management activities.
Monitoring regulatory changes and supporting sponsors and sites in preparing for regulatory inspections and audits.
Regulatory document preparation covers protocols, investigator's brochures, informed consent materials, and clinical study reports.
Submission maintenance handles amendments, annual reports, renewals, and responses, along with marketing authorization support for DCGI applications such as ND, SND, and FDC products.
Ensuring that clinical trials and medicinal products comply with applicable laws, regulations, ethical requirements, and regulatory guidelines throughout the product-development lifecycle.
Development strategy, regulatory consultation, document preparation, submission, regulatory review, responses and clarifications, approval, and post-approval maintenance.
Yes, we prepare and maintain regulatory dossiers such as Investigational New Drug (IND) applications or Clinical Trial Applications (CTAs), depending on the region.
We handle post-submission requirements such as amendments, annual reports, renewals, and responses, along with marketing authorization support.
By monitoring regulatory intelligence and supporting sponsors and clinical sites in preparation for regulatory inspections and audits.